Safety Lancet Market Research Report Information, by Type (Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet), by End User (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Other End Users) - Forecast to 2032

Global Safety Lancet Market Overview

Safety Lancet Market Size was valued at USD 2.89 Billion in 2023. The Global Safety Lancet industry is projected to grow from USD 3.23 Billion in 2024 to USD 5.45 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.56% during the forecast period (2024 - 2032).

A safety lancet is a small piece of medical equipment that is used for capillary blood sampling; it looks like a scalpel attached to a double-edged needle or blade. Lancets are a single user device and can be used for punchers, as for example finger sticks in order to obtain small blood specimens. A safety blood lancet is basically disposable.
The lancet market is a vital and dynamic component of the healthcare industry. The rise in developments in the devices of the healthcare industry such as treatment and prevention of several diseases and diagnosis is the major factor contributing to the growth of the safety lancet market. All the components of the health care industry play an important role in the safety lancet market size.  The increasing chronic diseases such as dyslipidemia, diabetes, and hyperlipidemia, and the increasing incidents of homecare diagnosis are some other major factors contributing to the growth of the safety lancet market.  Moreover, the high demand for the use of disposable blood lancet for pain-free diagnosis of hemoglobin, fat level, blood sugar level, and other important blood components are lily to propel the growth of the safety lancet market. The disposable lancet decreases the risk of the transmission of infection and blood transfusion which is again contributing to the growth of the global blood lancet market.
In December 2023, the country of India. Medtronic Private Limited, a business fully owned by Medtronic plc (NYSE: MDT), has introduced the Symplicity™ Spyral renal denervation system (RDN) for the treatment of hypertension. RDN, or Renal Denervation, is a less invasive therapeutic procedure that specifically focuses on nerves next to the kidneys, which may become hyperactive and result in hypertension. Medtronic has just received permission from the US Food and Drug Administration (FDA) for a system that has been developed over the course of 10 years of clinical research and development. This system has also been approved by regulatory authorities in India. 
The Symplicity SpyralTM blood pressure method has shown clinical effectiveness in decreasing elevated blood pressure, thereby minimizing significant health hazards. This treatment is minimally invasive and specifically targets the nerves surrounding the kidneys that can become hyperactive and lead to high blood pressure. Following sedation, the physician creates a small cut and introduces an extremely slender tube (catheter) into the artery that leads to the kidney. Subsequently, the physician employs the catheter to alleviate the heightened activity of the nerves linked to the kidney. The tube is extracted, without leaving any implant in place.
This report contains all the information on the safety lancet market trends, research, and market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the global safety lancet market forecast is also included in the report.
November 2022: Owen Mumford (Oxford, UK) showcased a range of advanced medical products, including safety pen needles, a venous blood collection kit, and capillary blood sample tools. The Unifine SafeControl device is a component of the company's range of safety pens used for administering insulin injections. Its purpose is to provide protection to medical personnel while ensuring a satisfactory degree of control. The Unistik Touch safety lancet by Owen Mumford incorporates comfort zone technology to minimize the discomfort associated with capillary blood sampling. The objective of the development of the Unistik Touch safety lancet was to simplify the procedure of obtaining capillary samples.  Users can activate the gadget by simply touching it on the designated area, causing the device to immediately power on. By implementing an automatic retraction mechanism, the device minimizes the chances of contamination, damage, and unauthorized reuse of the needle.
In June 2022, the CAES procured the Defense Logistics Agency's (DLA) Qualified Manufacturers List Class V (QML-V) rating for the cross-point switch. The customers of the company can be certain that these switches succeeded in going through the hardest trials and toughest test standards, thus making them suitable for use in the aerospace and defense industry.
In May 2021, Owen Mumford will add a capillary blood sampling device to their Unistik® Touch Portfolio, which will handle capillaries when very high amounts of blood are needed. This new contact-activated safety lancet (Blade: 2.0mm x 1.5mm) was created to provide a single-touch means of collecting capillary blood samples of up to 500 μl of blood. Unistik® Touch has one-touch activation to achieve simple capillary blood sampling procedures. There are various sizes of Unistik® Touch that cater to different volumes of blood that can be drawn employing Comfort Zone Technology® (CZT®). CZT®, on the other hand, is made up of several surface pressure points situated at the end closer to the patient on this safety lancet, which improves comfort while pressing against the site where a sample is being taken from during phlebotomy.
Covid 19 Analysis
The outbreak of the global pandemic covid 19 has affected every industry so far and it is likely to leave a long-term effect predicted to impact the growth of the safety lancet industry during the forecast period. According to the reports, the covid 19 has drastically changed the consumer’s behaviors and demand, the patterns of purchasing, dynamics of market forces, the supply chain, and the magnificent intervention of governments.
Safety Lancet Market Market Trends

Safety Lancet Market Drivers

The lancet market is highly driven by the rising prevalence of infectious diseases and different chronic diseases, along with improved medical device regulations, rising preference towards home healthcare, and the rising prevalence of diabetes. Moreover, the increasing support of the respective government and healthcare spreading has added fuel to the overall growth of the safety lancet market.

Safety Lancet Market Opportunities

The regulatory scenario is likely to put positive impacts on the global blood lancet market growth and hence creating opportunities for the same in the near future.

Safety Lancet Market Restraints

The low awareness among individuals regarding homecare lancet in developing economies around the globe is predicted to create hurdles in the growth of the lancet market.

Safety Lancet Market Challenges

The lack of awareness among the developing countries about the homecare usage of safety lancet devices can be considered as the major challenge which ultimately can create a hurdle in the growth of the safety lancet market.
Cumulative Growth Analysis
Blood sampling safety lancet is the most common device which is highly used in diagnostic centers, hospitals, clinics, and home care monitoring. The European region is predicted register exponential growth due to its rising demand and need for safe blood glucose tests in clinics, diagnostics centers, hospitals, etc, and the increased insulin users.
Value Chain Analysis
According to the reports, the safety lancet market has been segmented on the basis of types, end-users, and regions. On the basis of types, the safety lancet market is further segmented into push-button safety lancet, pressure-activated safety lancet, side button safety lancet. The safety lancet market is predicted to account for the maximum safety lancet market share due to its increasing usages for the treatment of patients who are suffering from diabetics. On the basis of end-users, the safety lancet market has been segmented into hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics, and other end users. 
The home care segment is dominating the safety lancet market in the year 2018 and it is predicted to dominate the market during the forecast period, owing to its magnificent increase in uses among the patients who are at homecare diagnosis of several chronic diseases including diabetes. Moreover, the ease and simplicity of the device make it easy to use and hence makes it an ideal device for monitoring diabetes and self-diagnosis which further aforementioned propel the growth of the safety lancet market.

Safety Lancet Market Segment Insights

The lancet market is segmented on the basis of the types, end-users, and regions. The safety lancet market is expected to witness decent growth during the forecast period.

Safety Lancet Application Insights

Based on the application, the lancet market is segmented into push-button safety lancet, pressure-activated safety lancet, side button safety lancet.

Safety Lancet End-Users Insights

Based on the propulsion types, the lancet market is segmented into hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics, and other end-users

Safety Lancet Regional Insights

According to the reports, on the basis of region, the safety lancet market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America is expected to dominate the safety lancet market in the year 2019 due to its favorable reimbursement policies and increasing numbers of patients in this region. The rising frequency of the launches of new products along with that the increasing expenditure of health care in this region is adding fuel to the growth of the safety lancet market in this region.
Asia Pacific region is predicted to register the fastest growth over the forecast period due to its upgraded healthcare infrastructure and the ring numbers of the patient pool who need diagnostic tests for treatment. The increasing incidents of chronic and infectious diseases like arboviral diseases including chikungunya, dengue, Zika, malaria, West Nile is rising the demand for safe lancet devices. Furthermost, the global pandemic covid 19 is also increasing demand for diagnostic testing in this region.
Competitive landscape
The reports of the lancet market include the primary research and the detailed analysis of quantitative and qualitative aspects of several experts of the industry and the key opinion of the key players in order to gain insight into the safety lancet market and the overall performance of the industries.
Safety Lancet Market Major Key Player

• F. Hoffmann-La Roche AG


• Becton, Dickinson and Company


• Terumo Medical Corporation


• Bayer AG


• HTL-STREFA S.A.


• Sarstedt AG & Co.


• Improve Medical Technology Co. Ltd

Report Overview
The following report comprises of –

•         Market overview 


•         Covid 19 Analysis


•         Market Dynamic


•         Drivers


•         Opportunities


•         Restraints 


•         Challenges


•         Cumulative Growth Analysis


•         Value Chain Analysis


•         Segmentation Overview 


•         By Application 


•         By End-Users


•         Regional Analysis


•         Competitive landscape

Recent Developments

• In 2018, HTL-STREFA expanded its storage capacity in Leczyca by almost 50%, with an equivalent of 3,550 m2 additional storage space.


• In 2018, HTL-STREFA was acquired by Investindustrial. This acquisition helped the company partner for diabetes management, thus serving an extensive customer base.


• In 2017, Owen Mumford opened its new facility in Malaysia to strengthen and accelerate the growth of the company in the Asia Pacific region.

Safety Lancet Market Segmentation

Safety Lancet Type Outlook

• Standard


• Safety Blood Lancets


• Vacuum Blood Lancets

Safety Lancet End-User Outlook

• Hospitals &Clinics


• Blood Banks


• Homecare


• Others

Safety Lancet Region Outlook

• North America
  
  
  
  • The U.S.
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • The U.K.
  
  
  • Germany
  
  
  • France
  
  
  • Italy
  
  
  • Spain
  
  
  • Czech Republic
  
  
  • Russia
  
  
  • Poland
  
  
  • Turkey
  
  
  • Switzerland
  
  
  
  


• Asia Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Vietnam
  
  
  • the Philippines
  
  
  • Malaysia
  
  
  • Indonesia
  
  
  • Thailand
  
  
  
  


• Latin America
  
  
  
  • Brazil
  
  
  • Mexico
  
  
  • Argentina
  
  
  • Colombia
  
  
  • Chile
  
  
  
  


• Middle East & Africa
  
  
  
  • South Africa
  
  
  • Saudi Arabia
  
  
  • UAE
  
  
  • Oman
  
  
  • Egypt
  
  
  
  

Attribute/Metric	Details
Market Size 2023	2.89 (USD Billion)
Market Size 2024	3.23 (USD Billion)
Market Size 2032	5.45 (USD Billion)
Compound Annual Growth Rate (CAGR)	14.56 % (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2019 - 2023
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Terumo Medical Corporation, Bayer AG, HTL-STREFA S.A., Sarstedt AG & Co., Improve Medical Technology Co. Ltd, others
Key Market Opportunities	The regulatory scenario is likely to put positive impacts on the global blood lancet market growth
Key Market Drivers	Rising prevalence of infectious diseases and different chronic diseases·  Improved medical device regulations.Rising preference towards home healthcare  The rising prevalence of diabetes